Chemoinformaics analysis of Linalyl anthranilate
| Molecular Weight | 273.376 | nRot | 6 |
| Heavy Atom Molecular Weight | 250.192 | nRig | 9 |
| Exact Molecular Weight | 273.173 | nRing | 1 |
| Solubility: LogS | -4.561 | nHRing | 0 |
| Solubility: LogP | 4.419 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 46.4302 |
| nHD | 1 | BPOL | 25.1078 |
| QED | 0.482 |
| Synth | 3.125 |
| Natural Product Likeliness | 1.435 |
| NR-PPAR-gamma | 0.02 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.192 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.438 |
| MDCK | 0.0000262 |
| BBB | 0.592 |
| PPB | 0.874889 |
| VDSS | 1.815 |
| FU | 0.0932956 |
| CYP1A2-inh | 0.888 |
| CYP1A2-sub | 0.27 |
| CYP2c19-inh | 0.943 |
| CYP2c19-sub | 0.648 |
| CYP2c9-inh | 0.659 |
| CYP2c9-sub | 0.494 |
| CYP2d6-inh | 0.857 |
| CYP2d6-sub | 0.283 |
| CYP3a4-inh | 0.924 |
| CYP3a4-sub | 0.222 |
| CL | 9.835 |
| T12 | 0.103 |
| hERG | 0.017 |
| Ames | 0.011 |
| ROA | 0.029 |
| SkinSen | 0.737 |
| Carcinogencity | 0.088 |
| EI | 0.958 |
| Respiratory | 0.672 |
| NR-Aromatase | 0.521 |
| Antiviral | Yes |
| Prediction | 0.760056 |